| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18613864 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 105 journal articles in the PubMed database | Email to a friend | | |
| Slovacek L, Ansorgova V, Macingova Z, et al.
Tamoxifen-induced QT interval prolongation. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Pharm Ther 2008 Aug; 33(4):453-5.
Abstract | Full Citation | Find Related Articles | | Fowble B, Fein DA, Hanlon AL, et al.
The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. [Journal Article]
Int J Radiat Oncol Biol Phys 1996 Jul 1; 35(4):669-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Johansen J, Overgaard J, Overgaard M
Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. [Journal Article]
Acta Oncol 2007; 46(4):525-33.
Abstract | Full Citation | Find Related Articles | | Moffat DF, Oien KA, Dickson J, et al.
Hepatocellular carcinoma after long-term tamoxifen therapy. [Case Reports, Journal Article]
Ann Oncol 2000 Sep; 11(9):1195-6.
Abstract | Full Citation | Find Related Articles | | Jahanzeb M
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women. [Journal Article]
Clin Ther 2007 Aug; 29(8):1535-47.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fisher B, Dignam J, Bryant J, et al.
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 1996 Nov 6; 88(21):1529-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN
Overview of resistance to systemic therapy in patients with breast cancer. [Journal Article, Research Support, Non-U.S. Gov't]
Adv Exp Med Biol 2007.:1-22.
Abstract | Full Citation | Find Related Articles | | Tormey DC, Gray R, Falkson HC
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 1996 Dec 18; 88(24):1828-33.
Abstract | Full Citation | Find Related Articles | | Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 1996 Nov 6; 88(21):1543-9.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
